• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION EXACTAMIX; SET, I.V. FLUID TRANSFER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION EXACTAMIX; SET, I.V. FLUID TRANSFER Back to Search Results
Model Number H938724E
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that an unspecified quantity of exactamix 2400 valve sets were leaking.During compounding, lipid injectable emulsion was observed leaking into ports 10/11 (nacl 30% and kcl 15%) and on occasion 15/16 (standard amino acid solutions).These leaks travel upstream slowly towards the container and occur only when lipid injectable emulsion is the ui and compounding all-in-one bags.These issues occurred during compounding prior to patient use.There was no patient involvement.No additional information is available.
 
Additional Manufacturer Narrative
Additional information: h4, h6, h11.H4: the lot was manufactured between december 14-15, 2022.H11: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
Additional information: h4: the lot was manufactured between december 14-15, 2022.H11: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXACTAMIX
Common Device Name
SET, I.V. FLUID TRANSFER
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
AVAILMED
c. industrial lt 001 mz 105
no 20905 int a, col cd ind
tijuana, baja california 22444
MX   22444
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key21556304
Report Number1416980-2025-01032
Device Sequence Number12805812
Product Code LHI
UDI-Device Identifier00085412475776
UDI-Public(01)00085412475776(10)60421940(17)250831
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K002705
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other
Remedial Action Notification
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date08/31/2025
Device Model NumberH938724E
Device Catalogue NumberH938724E
Device Lot Number60421940
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/11/2025
Supplement Date Received by Manufacturer09/25/2025
09/25/2025
Initial Report FDA Received Date03/09/2025
Supplement Report FDA Received Date10/24/2025
10/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
3010291427-06/21/2022-00
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALL-IN-ONE CONTAINER.; AMINOVEN.; SMOFLIPID.
Patient SexUnknown
-
-